TempoLife › Features › Rare-disease names and identifiers across systems

Rare-disease names and identifiers across systems

Rare-disease names and identifiers across systems: rare-disease names and identifiers across systems. This source-reviewed orientation page separates stable…

This launch guide maps the topic, the source base and the practical questions. Check the linked official authority before acting on a rule, deadline, price or safety requirement.

What this guide covers

Rare-disease names and identifiers across systems.

This source-reviewed orientation page separates stable preserve-the-exact-term-code-source-release-date-geography-population-definition-and-status principles from conclusions that depend on privacy suppression, changing borders and methods, self-reported or registered language, community variation and media rights, Braille code and tactile production, terminology release and mapping type, national medicine authorisation, product strength and form, current chemical law, supplier classification and the exact label and safety data sheet.

The named editions, URLs and reuse limits were checked on 2026-09-10. It remains outside search indexes pending a second-person clinical editorial review and localisation.

How to use it

Use Rare-disease names and identifiers across systems as a structured learning path: begin with the vocabulary, follow the evidence map, and keep the uncertainty labels attached to claims as you compare sources.

The page keeps the main question, its evidence base and its limits together in one canonical place. That makes it useful as a quick orientation and avoids splitting a broad subject into shallow pages before each narrower answer has enough verified material of its own.

Reviewed editorial notes

These concise notes are independently written from the source set below. In an emergency, use the local emergency number and follow the dispatcher rather than relying on a static page.

Resolve the ORPHAcode in a named release and entity type

Store Orphadata release, language, preferred label and synonyms, ORPHAcode, active or obsolete status, group/disorder/subtype type and any successor relationship. Use the downloadable CC BY 4.0 nomenclature rather than copying the personal-use Orphanet website. A similar name can refer to a group or subtype, and codes can be added, moved or retired, so every display needs release provenance and a route to the current record.

Sources for this note: Orphanet Scientific Knowledge Files — rare-disease nomenclature and alignments; Rare diseases and European Reference Networks.

Label mappings as mappings, not diagnoses or exact code conversions

Retain target system, version, relation type and review date for each ICD, OMIM, SNOMED CT or other alignment and show one-to-many, broader, narrower or unresolved relationships. TEHIK’s standards index demonstrates that terminology choice is implementation-specific in Estonian health systems. A name or ORPHAcode cannot diagnose a person, prove prevalence, determine reimbursement or referral, or replace the clinician and the coding rules of the receiving system.

Sources for this note: Orphanet Scientific Knowledge Files — rare-disease nomenclature and alignments; Health information terminology standards; Rare diseases and European Reference Networks.

Search vocabulary in four languages

Terminology changes across borders. These are example phrases people use for the same subject in Estonian, Finnish, Russian and English; they are included as a practical vocabulary aid, not as hidden keywords.

Reviewed sources and reuse boundaries

Authoritative source editions, URLs, scope and reuse limits were checked on 10 September 2026. The name, migration, regional-language, sign-language, Braille, rare-disease, medicine-identity and chemical-label notes are independently paraphrased and remain noindex pending second-person statistical, language-community, accessibility, clinical, pharmacy and chemical-safety review.

Source URLs and reuse terms checked: 2026-09-10. This date is not a guarantee that an external source has remained unchanged.

Scope and boundaries

This source-review release verifies the named editions, URLs, scope and reuse limits for the orientation page.

It remains outside search indexes: it is not evidence of any person’s identity, kinship, ethnicity, language, residence or migration status; a translation, fluent sign-language lesson or tactile-sign specification; a diagnosis or code conversion; medicine identification, substitution or prescribing advice; a chemical classification, complete handling instruction or emergency response; or a substitute for the current person-specific record, language community, accessibility specialist, clinician, pharmacist, product label, safety data sheet and competent authority.

Connected TempoLife guides

The following paths are the intentional hand-offs named in the brief. They keep adjacent subjects separate while making the next useful reference easy to find.

Why it belongs on TempoLife

/medterms.

Frequently asked questions